A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Oxytocin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Sep 2017 Status changed from not yet recruiting to recruiting.
- 28 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.